Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 2
1999 2
2000 3
2001 2
2002 2
2003 1
2004 1
2005 1
2011 1
2018 1
2019 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy.
Murakami K, Fujioka T, Okimoto T, Sato R, Kodama M, Nasu M. Murakami K, et al. Int J Antimicrob Agents. 2002 Jan;19(1):67-70. doi: 10.1016/s0924-8579(01)00456-3. Int J Antimicrob Agents. 2002. PMID: 11814770
This study investigated the relationship between the drug combinations of the eradication regimens and the prevalence of acquired resistance to clarithromycin. ...With the triple therapies, the percentages of patients acquiring clarithromycin resistant …
This study investigated the relationship between the drug combinations of the eradication regimens and the prevalence of acqui …
Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country.
Ahuja V, Dhar A, Bal C, Sharma MP. Ahuja V, et al. Aliment Pharmacol Ther. 1998 Jun;12(6):551-5. doi: 10.1046/j.1365-2036.1998.00338.x. Aliment Pharmacol Ther. 1998. PMID: 9678815 Free article. Clinical Trial.
In developing countries however, these combinations have neither been well evaluated, nor the optimum treatment for H. pylori infection well defined. ...METHODS: Sixty consecutive patients with active duodenal ulcer who were positive for H. pylori (by rapid urease test and …
In developing countries however, these combinations have neither been well evaluated, nor the optimum treatment for H. pylori infecti …
Comparison of seven and fourteen days of lansoprazole, clarithromycin, and amoxicillin therapy for eradication of Helicobacter pylori: a report from India.
Bhasin DK, Sharma BC, Ray P, Pathak CM, Singh K. Bhasin DK, et al. Helicobacter. 2000 Jun;5(2):84-7. doi: 10.1046/j.1523-5378.2000.00012.x. Helicobacter. 2000. PMID: 10849056 Clinical Trial.
However, there is a paucity of reports from developing countries on treatment duration of less than 14 days. We compared efficacy of 7 and 14 days of lansoprazole (L), clarithromycin (C), and amoxicillin (A) combinations for eradication of H. pylori. . …
However, there is a paucity of reports from developing countries on treatment duration of less than 14 days. We compared efficacy of 7 and 1 …
Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: a prospective study of 1-week lansoprazole, amoxycillin and clarithromycin in active peptic ulcer.
Ducóns JA, Santolaria S, Guirao R, Ferrero M, Montoro M, Gomollón F. Ducóns JA, et al. Aliment Pharmacol Ther. 1999 Jun;13(6):775-80. doi: 10.1046/j.1365-2036.1999.00549.x. Aliment Pharmacol Ther. 1999. PMID: 10383507 Free article.
BACKGROUND: Clarithromycin is a key antimicrobial in the combinations used to cure Helicobacter pylori infections, so there is a need to define the impact of in vitro resistance on in vivo results. ...CONCLUSIONS: Clarithromycin resistance significatively imp …
BACKGROUND: Clarithromycin is a key antimicrobial in the combinations used to cure Helicobacter pylori infections, so there is …
Helicobacter pylori eradication by sitafloxacin-lansoprazole combination and sitafloxacin pharmacokinetics in Mongolian gerbils and its in vitro activity and resistance development.
Yamamoto T, Takano T, Higuchi W, Nishiyama A, Taneike I, Yoshida K, Kanda H, Imamura Y. Yamamoto T, et al. Antimicrob Agents Chemother. 2011 Sep;55(9):4261-6. doi: 10.1128/AAC.01105-10. Epub 2011 Jul 5. Antimicrob Agents Chemother. 2011. PMID: 21730117 Free PMC article.
A total of 293 strains of Helicobacter pylori, including strains resistant to levofloxacin, clarithromycin, metronidazole, or amoxicillin, were examined for in vitro susceptibility to 10 antimicrobial agents. ...The therapeutic rates were 83.3% for the sitafloxacin …
A total of 293 strains of Helicobacter pylori, including strains resistant to levofloxacin, clarithromycin, metronidazole, or amox …
Amoxicillin/tetracycline combinations are inadequate as alternative therapies for Helicobacter pylori infection.
Perri F, Festa V, Merla A, Quitadamo M, Clemente R, Andriulli A. Perri F, et al. Helicobacter. 2002 Apr;7(2):99-104. doi: 10.1046/j.1083-4389.2002.00066.x. Helicobacter. 2002. PMID: 11966868 Clinical Trial.
AIM: To determine the efficacy and safety of three regimens consisting of amoxicillin and tetracycline or doxycycline combined with either lansoprazole or ranitidine bismuth citrate. ...(group LAT) or ranitidine bismuth citrate 400 mg b.i.d. (group RBCAT) for 7 days …
AIM: To determine the efficacy and safety of three regimens consisting of amoxicillin and tetracycline or doxycycline combined with e …
Helicobacter pylori eradication in Mexico with a levofloxacin-based scheme versus standard triple therapy: Results from an open-label, randomized, noninferiority phase iiib trial.
Ladrón-de-Guevara L, Bornstein-Quevedo L, González-Huezo S, Castañeda-Romero B, Costa FG, di Silvio-López M. Ladrón-de-Guevara L, et al. Rev Gastroenterol Mex (Engl Ed). 2019 Jul-Sep;84(3):274-283. doi: 10.1016/j.rgmx.2018.04.005. Epub 2018 Jul 27. Rev Gastroenterol Mex (Engl Ed). 2019. PMID: 30060902 Free article. Clinical Trial. English, Spanish.
To assess the noninferiority efficacy and safety of 210-day triple regimens on H. pylori eradication, we evaluated clarithromycin 500mg, lansoprazole 30mg, and amoxicillin 1g, all bid (standard triple therapy or CLA, Group 1) vs. pantoprazole 80mg, levofloxac …
To assess the noninferiority efficacy and safety of 210-day triple regimens on H. pylori eradication, we evaluated clarithromycin 500 …
Effect of ornidazole and clarithromycin resistance on eradication of Helicobacter pylori in peptic ulcer disease.
Lehmann FS, Drewe J, Terracciano L, Beglinger C. Lehmann FS, et al. Aliment Pharmacol Ther. 2000 Mar;14(3):305-9. doi: 10.1046/j.1365-2036.2000.00717.x. Aliment Pharmacol Ther. 2000. PMID: 10735923 Free article. Clinical Trial.
(LAO) or lansoprazole 30 mg o.d., amoxycillin 1 g b.d. and clarithromycin 500 mg b.d. ...RESULTS: Data from 80 patients with active peptic ulcer disease and positive H. pylori status were analysed. The prevalence of primary drug resistance was 25% for metroni …
(LAO) or lansoprazole 30 mg o.d., amoxycillin 1 g b.d. and clarithromycin 500 mg b.d. ...RESULTS: Data from 80 patients with a …
Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan.
Hoshiya S, Watanabe K, Tokunaga K, Tanaka A, Ninomiya H, Shingaki M, Itoh T, Saito S, Ishida H, Takahashi S. Hoshiya S, et al. J Gastroenterol. 2000;35(1):10-4. J Gastroenterol. 2000. PMID: 10632534
We investigated: (1) the usefulness of susceptibility tests prior to eradication therapy, and (2) the rate of acquisition of H. pylori resistance to clarithromycin after treatment failure. Drug susceptibility tests to clarithromycin and amoxicillin wer …
We investigated: (1) the usefulness of susceptibility tests prior to eradication therapy, and (2) the rate of acquisition of H. pylori resis …
18 results